Sonder Capital led a €12m Series A round in Vitestro.

Sonder Capital, a venture capital firm focused on partnering with bold changemakers to imagine, scale and accelerate the technologies that will transform healthcare, led a €12m Series A round in Vitestro, a provider of autonomous blood drawing technology. “This financing round marks a new phase of growth for Vitestro which brings the company closer to its mission of improving the venipuncture procedure for hundreds of millions of patients per year. We look forward to growing the business and transforming patient care with Sonder Capital, leveraging their expertise in successfully commercializing medical robotic technologies,” Toon Overbeeke, Vitestro CEO and co-founder.